AHA, others urge Supreme Court to bar excessive FCA penalties

The AHA, Pharmaceutical Research and Manufacturers of America, and U.S. Chamber of Commerce today urged the U.S. Supreme Court to bar civil monetary penalties under the False Claims Act that irrationally exceed the harm actually suffered by the government.

Key Resources

Related Resources

Advisory
Updated Medicare Advantage Question and Complaint Process for Provider Organizations
Member
Letter/Comment
AHA Supports House Securing Access to Care for Seniors in Critical Condition Act
Public
Advisory
CMS Issues Rate Announcement and Final Rule for CY 2026 Medicare Advantage, Prescription Drug Plans
Member
Letter/Comment
Senate Letter from AHA, Other Organizations in Support of Conrad State 30 and Physician Access Reauthorization Act S.709
Public
Letter/Comment
House Letter from AHA, Other Organizations in Support of Conrad State 30 and Physician Access Reauthorization Act (H.R.1585)
Public
Testimony
AHA Statement to House Ways and Means Subcommittee on Health for Hearing March 11, 2025
Public